Why doesnt SCL enable other laboratories to actually perform these new PTH tests?
In the mid 1970’s, the founder of Scantibodies developed first generation PTH assays. In the 1980’s, Scantibodies produced the first 2nd generation PTH assay antibodies for Nichols. In the 1990’s, Scantibodies discovered, developed, published and filed for patents on the 3rd generation PTH assays. Scantibodies Clinical Laboratory is a PTH reference lab that provides results in a way that is not the norm for the majority of testing laboratories. Unlike most testing laboratories, SCL runs its PTH tests from specimens that have been centrifuged immediately after blood draw. Then the EDTA plasma is immediately frozen and transported to the lab for testing. PTH tests are run in duplicate and our report is the mean of duplicates. Moreover, Scantibodies has played an active role in the discovery and development of the 3rd generation PTH assays. In order to preserve the integrity of this new PTH technology, only Scantibodies Clinical Laboratory offers these new PTH tests in the United States.
